Michael Mullette

Michael Mullette is an accomplished executive in the biotechnology and pharmaceutical industries, currently serving as Chief Commercial Officer at Vaxcyte since October 2025. Prior to this role, Michael held multiple key positions at Lykos Therapeutics, including Interim Chief Executive Officer and Chief Operating Officer from March 2022 to November 2025. At Moderna, from August 2020 to March 2022, Michael was Vice President of North America Commercial Operations, where responsibilities included leading commercialization activities during critical periods and managing vaccine purchase agreements. Michael's extensive career at Sanofi from 2001 to August 2020 featured roles such as General Manager and Country Chair for Sanofi Canada and General Manager for Sanofi Pasteur Japan, emphasizing P&L management, strategic negotiations with health authorities, and overseeing cross-functional teams. Michael holds an M.B.A. in Management from Lehigh University and dual Bachelor's degrees in Business Administration and Marketing from Villanova University.